009 - Gynaecologial Cancers & Eve Appeal - Athena Lamnisos & Dr Louise Newson
The Dr Louise Newson Podcast
Dr Louise Newson
4.7 • 933 Ratings
🗓️ 6 August 2019
⏱️ 37 minutes
🧾️ Download transcript
Summary
Athena Lamnisos is the Chief Executive of the Eve Appeal which the only UK national charity raising awareness and funding research into the five gynaecological cancers – womb, ovarian, cervical, vulval and vaginal. In this episode Dr Louise Newson and Athena talk about the importance of diagnosing these cancers early which leads to better outcomes for women. Many women are ignoring signs of potential cancer such as vaginal bleeding due to fear or denial which needs to change. Athena talks about ways the charity is working to improve early detection of cancers and also with the research they are involved in and the discussion also includes managing menopause in women who have had treatment for their cancer and how important it is for them to receive the right treatment and advice.
Athena's Three Take Home Tips for Understanding your Gynae Health:
- You need to know your menstrual health and cycle and know what's normal for you. If you no longer have periods, you need to know when your last one was.
- We need to break down the stigma and taboo around gynaecological health. Learn and use the correct terminology for your body parts so you can describe any symptoms properly.
- Know your body! Have a look at your vulva and know what is normal for you. This will help so much should you have to explain anything to a medical professional.
Transcript
Click on a timestamp to play from that location
| 0:00.0 | Welcome to the Newsome Health Menopause podcast. |
| 0:11.1 | I'm Dr Louise Newsome, a GP and menopause specialist, |
| 0:15.1 | and I run the Newsome Health Menopause and wellbeing centre here in Stratford-upon-Avon. |
| 0:31.7 | So hi, today I'm very excited. I've managed to get someone up from London into Stratford upon Avon, who is the CEO of the amazing charity called Eve Appeal. She's Amthina Lamnissos and we've worked together |
| 0:42.1 | on a few events, a few things. And every time I see patients who have had cancer of their |
| 0:48.9 | cervix or their ovary, I'm always overwhelmed and shocked by how a lot of them haven't had the right |
| 0:55.3 | help, certainly since their diagnosis with their menopause. So welcome. Thanks for coming. |
| 1:01.2 | Thank you. So before we really get started into menopause, which clearly is all I talk about, |
| 1:06.2 | I thought we'd take a step back and just ask a bit about the charity, what it is and also your involvement. |
| 1:13.5 | How did you become to be involved with it? Yeah, well, thanks very much. And you've just used |
| 1:18.3 | a really interesting phrase there, take a step back. And that's very much what we do as a cancer |
| 1:24.6 | charity. So we're really very different as a cancer charity. We are trying to stop |
| 1:31.6 | cancer before it starts. So, you know, there are many, many cancer charities out there, |
| 1:37.4 | an amazing hospice movement that's out there as well. But we're trying to stop cancer, as I say. |
| 1:44.1 | So we're focused on prevention cancer, as I say. |
| 1:49.4 | So we're focused on prevention and awareness raising of the signs, symptoms and the fact that these cancers even exist. |
| 1:51.2 | So what do we do? |
| 1:53.1 | We do three things. |
| 1:54.5 | We fund medical research, and that's medical research focused across the five |
| 1:59.7 | gyne cancers. |
| 2:00.5 | So they are womb, sometimes known as |
| 2:03.9 | endometrial or uterine cancer. And it doesn't help that we kind of use three words interchangeably |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from Dr Louise Newson, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of Dr Louise Newson and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2026.

